| http://dbpedia.org/ontology/abstract
|
MDMB-CHMICA is an indole-based synthetic c … MDMB-CHMICA is an indole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug. While MDMB-CHMICA was initially sold under the name "MMB-CHMINACA", the compound corresponding to this code name (i.e. the isopropyl instead of t-butyl analogue of MDMB-CHMINACA) has been identified on the designer drug market in 2015 as AMB-CHMINACA.igner drug market in 2015 as AMB-CHMINACA.
|
| http://dbpedia.org/ontology/casNumber
|
1971007-95-0
|
| http://dbpedia.org/ontology/fdaUniiCode
|
X6JI7EA6EJ
|
| http://dbpedia.org/ontology/pubchem
|
125181404
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/MDMB-CHMICA.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
47106210
|
| http://dbpedia.org/ontology/wikiPageLength
|
13741
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1095519646
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Member_state_of_the_European_Union +
, http://dbpedia.org/resource/Category:Indolecarboxamides +
, http://dbpedia.org/resource/Synthetic_cannabinoid +
, http://dbpedia.org/resource/Bradycardia +
, http://dbpedia.org/resource/Agonist +
, http://dbpedia.org/resource/Controlled_Substances_Act +
, http://dbpedia.org/resource/EC50 +
, http://dbpedia.org/resource/Cannabinoid_receptor_type_1 +
, http://dbpedia.org/resource/Category:Indoles +
, http://dbpedia.org/resource/MDMB-CHMINACA +
, http://dbpedia.org/resource/AMB-CHMINACA +
, http://dbpedia.org/resource/AB-CHMINACA +
, http://dbpedia.org/resource/MDMB-FUBINACA +
, http://dbpedia.org/resource/European_Union +
, http://dbpedia.org/resource/Category:Cannabinoids +
, http://dbpedia.org/resource/Designer_drug +
, http://dbpedia.org/resource/PX-3 +
, http://dbpedia.org/resource/European_Monitoring_Centre_for_Drugs_and_Drug_Addiction +
, http://dbpedia.org/resource/ADB-CHMINACA +
, http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Intrinsic_activity +
, http://dbpedia.org/resource/European_Commission +
, http://dbpedia.org/resource/Implementing_act +
, http://dbpedia.org/resource/JWH-018 +
, http://dbpedia.org/resource/Indole +
|
| http://dbpedia.org/property/c
|
23
|
| http://dbpedia.org/property/casNumber
|
1971007
|
| http://dbpedia.org/property/chemspiderid
|
34450863
|
| http://dbpedia.org/property/h
|
32
|
| http://dbpedia.org/property/iupacName
|
Methyl -2-{[1--1H-indol-3-yl]formamido}-3,3-dimethylbutanoate
|
| http://dbpedia.org/property/legalCa
|
Schedule II
|
| http://dbpedia.org/property/legalDe
|
Anlage II
|
| http://dbpedia.org/property/legalStatus
|
Illegal in Austria, China, Brazil, Croatia, Denmark, Estonia, Finland, Greece, Hungary, Latvia, Lithuania, Luxembourg, Norway, Poland, Turkey, Sweden and Switzerland
|
| http://dbpedia.org/property/legalUk
|
Class B
|
| http://dbpedia.org/property/legalUs
|
Schedule I
|
| http://dbpedia.org/property/n
|
2
|
| http://dbpedia.org/property/o
|
3
|
| http://dbpedia.org/property/pubchem
|
125181404
|
| http://dbpedia.org/property/smiles
|
COC[C@@H]CC
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
SRJKCVHWIDFUBO-HXUWFJFHSA-N
|
| http://dbpedia.org/property/unii
|
X6JI7EA6EJ
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Cannabinoids +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Div_col +
, http://dbpedia.org/resource/Template:Div_col_end +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cannabinoidergics +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Category:Indoles +
, http://dbpedia.org/resource/Category:Indolecarboxamides +
, http://dbpedia.org/resource/Category:Cannabinoids +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Cannabinoid +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/MDMB-CHMICA?oldid=1095519646&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/MDMB-CHMICA.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/MDMB-CHMICA +
|
| owl:sameAs |
http://dbpedia.org/resource/MDMB-CHMICA +
, http://yago-knowledge.org/resource/MDMB-CHMICA +
, http://www.wikidata.org/entity/Q27279559 +
, https://global.dbpedia.org/id/2Z6MK +
|
| rdf:type |
http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/ontology/ChemicalSubstance +
|
| rdfs:comment |
MDMB-CHMICA is an indole-based synthetic c … MDMB-CHMICA is an indole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug. While MDMB-CHMICA was initially sold under the name "MMB-CHMINACA", the compound corresponding to this code name (i.e. the isopropyl instead of t-butyl analogue of MDMB-CHMINACA) has been identified on the designer drug market in 2015 as AMB-CHMINACA.igner drug market in 2015 as AMB-CHMINACA.
|
| rdfs:label |
MDMB-CHMICA
|
